Parametric or non-parametric comparisons were used as dictated by data distribution
Type 2 Diabetes Focus Tirzepatide Tirzepatide has 5 SURPASS T2D trials, FDA approval for diabetes (Mounjaro), and demonstrated superiority over semaglutide in SURPASS-2
Basic management includes inotropic therapy, preload and afterload reduction, with diuretics, digoxin, and ACE inhibitors as first-line treatments
The consistently higher HbA1C levels in the GLP-1 RAs group throughout the study suggesting the pleiotropic effects of GLP1RAs additional to glucose lowering effect 21
In spine trauma, any direction of force induction into the intervertebral disc such as compression, distraction and rotation/translation can lead to a disc injury or disc failure depending on the involved energy
Your Personalized Plan and Continued Support If approved for therapy, you'll begin a personalized weight loss plan designed specifically for your needs and medical profile